1. Home
  2. OCG vs STXS Comparison

OCG vs STXS Comparison

Compare OCG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oriental Culture Holding LTD

OCG

Oriental Culture Holding LTD

HOLD

Current Price

$0.23

Market Cap

218.1M

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$2.38

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCG
STXS
Founded
2018
1990
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.1M
210.0M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
OCG
STXS
Price
$0.23
$2.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
19.7M
471.8K
Earning Date
11-14-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$316,807.00
$30,075,000.00
Revenue This Year
N/A
$24.48
Revenue Next Year
N/A
$29.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.62
52 Week Low
$0.20
$1.54
52 Week High
$19.29
$3.59

Technical Indicators

Market Signals
Indicator
OCG
STXS
Relative Strength Index (RSI) 40.59 44.44
Support Level $2.60 $2.34
Resistance Level $19.29 $2.44
Average True Range (ATR) 2.72 0.10
MACD -0.05 0.03
Stochastic Oscillator 0.09 55.17

Price Performance

Historical Comparison
OCG
STXS

About OCG Oriental Culture Holding LTD

Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance services to customers. The company operates through one segment, namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: